Search the Newsreel

ENSG Investor News: If You Have Suffered Losses in Ensign

The Rosen Law Firm is investigating potential securities claims against The Ensign Group, Inc. (NASDAQ: ENSG) following a short seller report alleging the company's business model relies on inadequate patient care and "gaming quality metrics." Investors who purchased Ensign securities and suffered losses are …

Intensity Therapeutics resumes patient dosing in Swiss trial

Intensity Therapeutics Inc. has resumed patient dosing in its INVINCIBLE-4 Study in Switzerland for early-stage, operable triple-negative breast cancer, following a temporary pause due to skin irritation. The company's stock has faced volatility, but analysts maintain a bullish outlook, with InvestingPro suggesting it is …

Intensity Therapeutics restarts 61-patient breast cancer trial

Intensity Therapeutics has restarted its INVINCIBLE-4 trial for breast cancer after pausing due to skin irritation. The company will now recruit an additional 47 patients in Switzerland and France using an amended single-injection protocol. Preliminary results from the first 14 patients show promising pathological …

Sensient Technologies (SXT) Q1 2026 Earnings: EPS Surges Past Estimates Despite Flat Stock Reaction - Tangible Book Value

REG - EnSilica PLC - Result of Retail Offer and Notice of GM

EnSilica secures £14 million in oversubscribed AIM fundraising to support expansion (ENSI)

EnSilica raises £14m to support expansion

REG - EnSilica PLC - Result of oversubscribed Placing and Subscription

ENSI Forecast — Price Target — Prediction for 2027

Ensign Energy And 2 Global Energy Stocks With Earnings Growth

Sensient Technologies Corporation (SXT) Q1 2026 Earnings: Stellar EPS Beat Drives Stock Rally - Margin Improvement Report

XPS Pensions FY26 slides: strong results, growth to moderate

XPS Pensions reports profit above estimates on advisory growth

Nano Dimension: Controversial Move Offers Promise Amidst Uncertainty (Rating Downgrade)

XPS Pensions Group Plc Reports Record Revenue And Profit Growth For FY 2026

Nano Dimension and Infinite Epigenetics Provide Additional Information Regarding Proposed Business Combination

EnSilica shares rise 9% on $75 million chip supply contract By Investing.com

Nano Dimension Earnings Call: Growth, Cash, and Turmoil

Earnings call transcript: Expensify Q1 2026 misses EPS forecast, stock dips

Expensify (EXFY) Earnings Date and Reports 2026 $EXFY

Nano Dimension: What Shareholders Might Expect From Strategic Alternatives (NASDAQ:NNDM)

Nano Dimension (NNDM) Q4 2025 Earnings Transcript

Earnings call transcript: Nano Dimension’s Q1 2026 sees strong revenue growth but EPS loss

ENSG Q1 Deep Dive: Acquisition-Driven Growth and Clinical Excellence Amid Revenue Shortfall

Nano Dimension Stock Reshapes Portfolio With AME Sale

Nano Dimension Stock Shifts As AME Sale Cuts Cash Burn

The Ensign Group (NASDAQ:ENSG) Reports Sales Below Analyst Estimates In Q1 CY2026 Earnings

Earnings Estimates Moving Higher for Sensient (SXT): Time to Buy?

Ensign posts Q1 results April 30, investors hear details May 1

Ensign Group (ENSG) Earnings Expected to Grow: Should You Buy?

Earnings call transcript: Sensient Technologies Q1 2026 beats expectations, stock surges

Nano Dimension to Host Q1 2026 Financial Results Conference Call

XPS Pensions delivers 'another year of record results'

The Ensign Group (ENSG): Buy, Sell, or Hold Post Q4 Earnings?

Nano Dimension: Proving The Markforged Acquisition Is More Than Just Revenue Growth (NNDM)

Nano Dimension Ltd. (NNDM) Stock Falls on Q4 2025 Earnings